Include Pharmacogenomic Approaches In All Phases Of Drug Development

Clinical Trials

The U.S. Department of Health and Human Services, the Food and Drug Administration, the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), and the Center for Devices and Radiological Health (CDRH) have all provided guidance for early-phase clinical studies and recommendations for labeling.

Correlate Trial Results With Genetic Data

Coastal Lab Partners will work in concert with academic researchers and commercial enterprises to help correlate clinical trial results with genetic data. This is increasingly important whether trials are early-phase or moving into stage three trials.

Contact

Coastal Lab Partners LLC

747 Main Street, Suite 112
Concord, MA 01742

857.366.7743
info@coastalpgx.com

Coastal Lab Partners LinkedIn Logo

COASTAL LAB PARTNERS | COPYRIGHT © 2016 COASTAL LAB PARTNERS, LLC. | PRIVACY AND TERMS OF USE | INFO@COASTALPGX.COM